{
  "ptid_time": "033_S_0513_2006-05-18",
  "img_path": "/data/qiuhui/data/adni/images/033_S_0513/2006-05-18/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 44,622 mm³, 48.6% above the reference mean. With a Z-score of 1.16 (87.6th percentile), this represents mild enlargement; hippocampal volume measures 7,256 mm³, 9.6% below the reference mean. With a Z-score of -0.96 (16.9th percentile), this represents normal volume ; whole brain volume measures 1,092,060 mm³, 3.7% below the reference mean. With a Z-score of -0.53 (29.8th percentile), this represents normal volume ; entorhinal cortex volume measures 2,678 mm³, 37.2% below the reference mean. With a Z-score of -2.57 (0.5th percentile), this represents significant atrophy; fusiform gyrus volume measures 15,404 mm³, 22.6% below the reference mean. With a Z-score of -1.88 (3.0th percentile), this represents moderate atrophy; middle temporal gyrus volume measures 21,793 mm³, 2.8% below the reference mean. With a Z-score of -0.23 (41.0th percentile), this represents normal volume . ",
  "text_data": "Age is 68.9 years. Gender is Male. Education: 18 years. Handedness: Right. Race: White. Medical history: Neurologic; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Musculoskeletal; Gastrointestinal; Renal-Genitourinary; Allergies or Drug Sensitivities; Major Surgical Procedures. MMSE: 28.0. Logical Memory: 6.0. APOEε4 alleles: 2.0. ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The data shows significant atrophy in the entorhinal cortex (Z-score -2.57) and moderate atrophy in the fusiform gyrus (Z-score -1.88), both key regions affected in Alzheimer's disease. Despite normal hippocampal volume and a high MMSE score (28/30), the presence of APOE4 homozygosity (2 alleles) increases Alzheimer's risk.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely prodromal Alzheimer's due to biomarker evidence despite preserved cognition).  \n\n**Confidence:** **Medium** (MMSE is borderline normal, but structural atrophy and APOE4 status strongly suggest early neurodegeneration).  \n\n*Note: A follow-up cognitive assessment (e.g., MoCA) and CSF/PET biomarkers (e.g., amyloid/tau) would strengthen confidence.*",
  "timestamp": "2025-07-26T05:10:26.076087"
}